TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome April 22, 1983
TCL Archive NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts. May 12, 2006